Impact of Free Mobility on FDG Uptake in PET Scans
Impact of Free Mobility on FDG Uptake During a PET Scan: Randomized Controlled Non-inferiority Study
Centre Hospitalier Régional d'Orléans
284 participants
Apr 30, 2025
INTERVENTIONAL
Conditions
Summary
Positron Emission Tomography (PET) is a rather long examination (around 2 hours), involving an injection of 18F-Fluorodeoxyglucose (FDG), which requires the patient to rest for 1 hour between the injection and the start of imaging. Some hospitals allow the patient to sit, read or use the telephone, but none allow the patient to move freely after injection, hence the interest of this work. The aim of this study is to demonstrate that free mobilization of the patient following 18F-FDG injection does not result in any significant difference in imaging quality (particularly muscular fixations), and therefore a medical interpretation identical to that of a patient who remains at rest.
Eligibility
Inclusion Criteria2
- Adults
- Patient referred for FDG PET (excluding brain PET) and carried out on an outpatient basis.
Exclusion Criteria6
- Bedridden patients
- Protected person (under guardianship or curatorship)
- Persons under court protection
- Persons deprived of liberty
- Persons not affiliated to a social security scheme
- Pregnant or breast-feeding woman
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Free mobility between FDG injection and scanning (without exiting the Nuclear Medicine Department)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06799819